Study guide

Phakic IOLs and refractive lens exchange

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Phakic IOLs and refractive lens exchange

Key Takeaways Explain This Topic AI

Phakic implants retain the natural lens but require device-specific chamber, endothelial and sizing criteria.

Low or high vault must be interpreted with lens contact, angle, pressure and clinical findings.

Refractive lens exchange removes accommodation and can increase retinal-detachment risk, especially in susceptible myopic eyes.

Last updated: October 2026

When refractive errors exceed the safe tissue limits of keratorefractive photoablation (such as myopia > − 8.00 D > -8.00\text{ D} > − 8.00 D or hyperopia > + 4.00 D > +4.00\text{ D} > + 4.00 D ), or when corneal thickness or topography is unfavourable, lens-based refractive surgery becomes the preferred modality. Lens-based refractive surgery is divided into two broad categories:

Phakic Intraocular Lenses (PIOLs) : Implantation of an artificial lens into the anterior or posterior chamber while preserving the clear natural crystalline lens and crystalline accommodation.

Refractive Lens Exchange (RLE) : Surgical removal of the clear crystalline lens via phacoemulsification followed by intraocular lens (IOL) implantation, analogous to cataract surgery.

1. Indications & Optical Advantages of Phakic IOLs

Phakic IOLs provide distinct optical and physiological benefits over excimer laser photoablation in high ametropias:

Preservation of Accommodation : The patient's natural crystalline lens remains untouched, allowing young pre-presbyopic patients to maintain dynamic accommodation.

Optical Superiority & Contrast Sensitivity : High myopic excimer ablation profiles induce significant positive spherical aberration ( Z 4 0 Z_4^0 Z 4 0 ​ ), degrade the natural prolate corneal asphericity, and reduce mesopic contrast sensitivity. Phakic IOL optics are placed closer to the eye's nodal point, producing larger retinal image magnification (reducing myopic minification) and superior visual quality without altering corneal topography.

Reversibility : Unlike keratorefractive surgery, PIOL implantation is surgically reversible; the lens can be explanted or exchanged if refractive targets shift, cataracts develop, or complications occur.

Clinical Eligibility Criteria

Age and range : Use the current model-specific local instructions for use, stable refraction and lens/angle status.

Refractive Stability : Refractive shift ≤ 0.50 D \le 0.50\text{ D} ≤ 0.50 D over the preceding 12 months.

Correction range : Depends on model and authorisation; avoid generic ranges covering all phakic lenses.

Contraindications to Cornea-Based Surgery : Central corneal thickness < 480 – 500 μ m < 480–500\,\mu\text{m} < 480–500 μ m , expected residual stromal bed < 300 μ m < 300\,\mu\text{m} < 300 μ m , expected PTA ≥ 40 % \text{PTA} \ge 40\% PTA ≥ 40% , or suspicious topography (forme fruste keratoconus).

2. Anatomical Classification & Lens Models

Phakic IOLs are categorised by their anatomical site of fixation within the eye:

1. Anterior Chamber Angle-Supported PIOLs (Historical / Obsolete)

Early models (e.g., NuVita MA20, ZSAL-4, AcrySof Cachet) featured flexible haptics positioned directly into the iridocorneal angle recess. Although surgically simple, they resulted in unacceptably high rates of long-term complications:

Progressive Endothelial Cell Loss : Chronic micro-movement and peripheral contact with corneal endothelium during blinking or ocular rubbing led to late corneal decompensation.

Pupil Ovalisation : Chronic mechanical compression and ischaemic atrophy of the iris root by angle footplates.

Secondary Glaucoma : Progressive formation of peripheral anterior synechiae (PAS) and chronic low-grade trabeculitis.

Current status : Many historical angle-supported designs were discontinued because of endothelial safety concerns; existing implants still require surveillance, and availability is jurisdiction-specific.

2. Anterior Chamber Iris-Fixated PIOLs (Artisan / Artiflex)

Designed by Jan Worst, these lenses feature two opposing claw haptics that enclave a fold of mid-peripheral, immobile iris stroma:

Models : Artisan (rigid polymethylmethacrylate [PMMA], requiring a 5.2 – 6.2 mm 5.2–6.2\text{ mm} 5.2–6.2 mm incision) and Artiflex (foldable silicone optic with PMMA haptics, injectable through a 3.2 mm 3.2\text{ mm} 3.2 mm incision).

Anatomical Safety : The optic is held elevated over the pupil, maintaining clearance from the delicate trabecular meshwork and angle structures.

Mandatory Peripheral Iridectomy : Because the lens optic sits over the pupil, a surgical peripheral iridectomy (or preoperative Nd:YAG laser iridotomy) is mandatory to prevent pupillary block angle-closure glaucoma.

Complications : Endothelial cell loss (requiring strict annual monitoring), pigment dispersion, nocturnal glare/halos, and traumatic disenclavation following blunt ocular injury.

3. Posterior Chamber Sulcus-Supported PIOLs: The Implantable Collamer Lens (ICL)

The Visian ICL (STAAR Surgical) is currently the predominant phakic IOL worldwide. It is positioned entirely within the posterior chamber, resting in the ciliary sulcus behind the iris and in front of the anterior crystalline lens capsule.

Material Science: Collamer

Collamer is a proprietary biocompatible polymer composed of poly-hydroxyethylmethacrylate (poly-HEMA) , water ( 34 % 34\% 34% ), and a small quantity ( 0.2 % 0.2\% 0.2% ) of purified porcine collagen , integrated with a benzophenone UV-absorbing chromophore:

The material carries a negative surface charge , which repels negatively charged circulating serum proteins and inflammatory cells.

Biocompatibility reduces but does not eliminate inflammatory responses or other complications. Do not describe a material as immunologically invisible.

The EVO Visian ICL (Central KS-Aquaport Design)

Earlier ICL iterations (V4 model) required preoperative Nd:YAG laser iridotomies to prevent aqueous entrapment and pupillary block. The modern EVO Visian ICL (V4c and V5 models) incorporates a patented 360 μ m 360\,\mu\text{m} 360 μ m central hole (KS-Aquaport) along with two 360 μ m 360\,\mu\text{m} 360 μ m peripheral flow ports:

Fluid Dynamics : Aqueous humour synthesised by the ciliary body flows unimpeded from the posterior chamber through the central port directly into the anterior chamber.

Elimination of Iridotomy : Completely obviates the requirement for preoperative or intraoperative peripheral iridotomies, eliminating risks of laser-induced hyphema, iritis, or dysphotopsias.

Preservation of Lens Physiology : Facilitates continuous aqueous nutrient circulation over the anterior crystalline lens capsule, significantly lowering the incidence of cataract formation.

3. Preoperative Assessment & Safety Criteria

Confirm stable refraction, functional goals, clear crystalline lens, open angles and the absence of glaucoma or active inflammation. Obtain a dilated retinal examination and discuss myopia-related disease. Measure endothelial cell density, internal anterior-chamber depth and dimensions used for sizing. Internal ACD is measured from endothelium to anterior lens capsule, rather than epithelium.

Age range, ACD, endothelial thresholds and correction range depend on the particular model and current instructions for use in the intended jurisdiction. Do not copy a generic age/ECD table between devices. The FDA extended the US EVO/EVO+ age indication to 21–60 in 2026; this does not establish European labelling for every phakic IOL. See the FDA approval supplement for that specific change.

Sizing may use white-to-white and ACD according to the manufacturer; ultrasound biomicroscopy can add sulcus and ciliary-body information. Each method has measurement uncertainty. Repeat inconsistent dimensions and consider anatomy, including cysts and angle crowding. A thin cornea alone does not make a patient suitable for a phakic lens.

The central-port EVO design generally removes the requirement for preoperative iridotomy used with older non-port models. Port obstruction, retained viscoelastic and excessive crowding can still cause pressure problems. Follow the actual device's perioperative and monitoring instructions.

4. Post-ICL Vault Measurement & Clinical Management

The vault is defined as the perpendicular distance between the posterior surface of the ICL optic and the anterior crystalline lens capsule measured along the visual axis. It is evaluated quantitatively via Anterior Segment Optical Coherence Tomography ( AS-OCT ) or high-resolution Scheimpflug imaging.

Vault Categories & Clinical Consequences

Vault interpretation: Approximately 250–750 micrometres is a commonly used clinical range, not a universal safety boundary. Interpret vault with model, angle, pressure, lens clarity and endothelial findings.

Finding Clinical assessment Response

Low vault or lens contact Assess anterior lens opacity and actual contact Monitor or revise according to findings and model guidance

Higher vault Assess angle crowding, pressure and endothelial distance Reassess sizing and consider intervention if adverse effects occur

Apparently acceptable vault Still assess vision, pressure, lens and endothelium Continue the model-specific follow-up programme

Longitudinal Endothelial Monitoring Protocol

Normal physiological endothelial cell loss in adults is approximately 0.6 % 0.6\% 0.6% per year .

Following phakic IOL implantation, surgical trauma induces an acute drop of 1 – 5 % 1–5\% 1–5% within the first 6 months, after which annual loss should plateau towards physiological levels.

Endothelial surveillance : Monitor serial counts and corneal/angle status according to the device label. Progressive loss or other harm may require explantation; a universal annual percentage or cell threshold cannot replace model-specific and clinical assessment.

5. Refractive Lens Exchange (RLE)

Refractive Lens Exchange (RLE)—also termed clear lensectomy—entails the removal of an unclouded crystalline lens via phacoemulsification and capsular bag implantation of an IOL (monofocal, toric, extended depth of focus [EDOF], or multifocal/trifocal).

Clinical Indications

Presbyopic hyperopia: Lens extraction can provide refractive correction and deepen the anterior chamber, reducing the lens-related component of angle closure. It does not eliminate every lifelong glaucoma mechanism.

Presbyopia: Selected patients may choose monofocal, toric or presbyopia-correcting IOLs after discussing optical compromises and surgical risk.

The Severe Retinal Hazard in Young Axial Myopes

Young high myopes need particular caution: extraction removes remaining accommodation and may increase retinal-detachment risk. Risk depends on axial length, age, peripheral retinal findings, vitreous status and surgical complications, so a single 10-year percentage or threefold multiplier is misleading. Discuss spectacles, contact lenses and suitability for corneal or phakic-lens procedures; a phakic IOL is not automatically suitable. A personalised informed decision is required.